MP30-14 TRENDS IN INFERTILITY CARE AND TREATMENT IN THE UNITED STATES: DATA FROM THE NATIONAL SURVEY FOR FAMILY GROWTH

Abstract

You have accessJournal of UrologyCME1 Apr 2023MP30-14 TRENDS IN INFERTILITY CARE AND TREATMENT IN THE UNITED STATES: DATA FROM THE NATIONAL SURVEY FOR FAMILY GROWTH Edouard Nicaise and Michael Eisenberg Edouard NicaiseEdouard Nicaise More articles by this author and Michael EisenbergMichael Eisenberg More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000003258.14AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: Male infertility is common. However, only half of infertile men seek care. Our objective was to identify trends in infertility diagnosis and treatment of men in the United States and associated factors over the past 20 years in the United States METHODS: We analyzed data from the National Survey for Family Growth (NSFG), a nationally representative sample of men aged 18-45 using cycles from 2002 to 2019. The cycles from 2015 on expanded to include men aged 18-49. Identification of infertility workup and management were determined by survey response. Demographic, socioeconomic, and reproductive characteristics were analyzed. We also included respective partner information. All descriptive population estimates, and statistical analyses accounted for the complex survey design, and sample weights were adjusted across survey years following official NSFG instructions. We combined all men across survey years for multivariate logistic regression model. Stata version 15.1 (College Station, TX) was used for analyses. RESULTS: The number of men who reported infertility evaluation in the six combined NSFG survey cycles is 1621 out of 34398 (4.7%). Age distribution at time of last infertility visit, education, race, and BMI did not differ significantly over time. In contrast, the average age of female partner increased significantly (p<0.001) in later cycles. The proportion of men reporting infertility testing increased over time from 51.8% in 2002 to 68.5% by 2019 (p=0.011). Men in the 2017-2019 cycle had twice the odds of undergoing testing compared to 2002-2003 (95% CI: 1.35-3.44). Moreover, there was a significant difference in the types of infertility treatments performed over time (p=0.009). Rate of having a biological child born after infertility evaluation increased over time (p=0.013). White race OR 1.85, 95% CI: 1.38-2.47), college education (OR 1.5 (1.23-2.21), and increased age were all positively associated with the use of infertility testing. When examining race, white men had 1.5 (1.08-2.18) the odds of being given a male factor diagnosis compared to nonwhites. In addition, white race, and age over 30 were more likely to report infertility treatment. White race and higher education were associated with a higher odd of reporting a biological child after evaluation. In contrast, nonwhite men reported less male factor diagnoses and infertility treatments over time. CONCLUSIONS: Infertility testing in the United States has increased from 2002 to 2019 across all patient demographics. There has also been an increase in men fathering a biological child following visits to discuss infertility. However, white men and men with a college degree are more likely to undergo infertility testing and father a biological child after infertility visits. While infertility testing and successfully treatments appear to be increasing over time, there appears to be disparities regrading receipt of infertility services. Source of Funding: None © 2023 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 209Issue Supplement 4April 2023Page: e396 Advertisement Copyright & Permissions© 2023 by American Urological Association Education and Research, Inc.MetricsAuthor Information Edouard Nicaise More articles by this author Michael Eisenberg More articles by this author Expand All Advertisement PDF downloadLoading ...